Yanming Biology
Changping
About Yanming Biology
Pyrotech pharmaceuticals is a biotechnology company that focuses om development for drugs for the treatment of inflammation and tumors.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $96.8M
- Funding stage: Early Stage Venture
- Last round: Series A (May 2024)
- Website: pyrotech.com
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/yanming-biology-57282 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.